Wanjia Group Holdings Limited (HKG:0401)

Market Cap	67.23M +41.2%
Revenue (ttm)	163.70M -4.5%
Net Income	-8.58M
EPS	-0.02
Shares Out	560.22M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	576,340
Open	n/a
Previous Close	0.1200
Day's Range	n/a
52-Week Range	0.0490 - 0.1820
Beta	1.37
RSI	51.77
Earnings Date	Jun 18, 2026

About Wanjia Group Holdings

Wanjia Group Holdings Limited, an investment holding company, engages in the wholesale and distribution pharmaceutical business in the Mainland China and Hong Kong. The company offers hemodialysis treatment and consultancy services. It sells its products to hospitals and healthcare institutions; and companies operating pharmaceutical retail chain stores, independent pharmacies, outpatient departments of community hospitals, healthcare service stations, and clinics. Wanjia Group Holdings Limited was founded in 2004 and is headquartered in Kowloo...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2004
• Employees: 177
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0401

Financial Performance

In fiscal year 2025, Wanjia Group Holdings's revenue was 161.69 million, a decrease of -10.71% compared to the previous year's 181.09 million. Losses were -6.62 million, -83.45% less than in 2024.